Table 5.
Predictors of Use of Nonprescription Analgesics, NSAIDs, and Cox-2 Inhibitors, Osteoarthritis Cohort
Correlate | Nonprescription Analgesic | NSAIDs | Cox-2 Inhibitor |
---|---|---|---|
White | 1.0 | 1.0 | 1.0 |
African American | 1.39 (0.96, 2.0)+ | 0.61 (0.41, 0.90)** | 0.71 (0.46, 1.08) |
Male | 1.0 | 1.0 | 1.0 |
Female | 1.07 (0.75, 1.5) | 1.19 (0.81, 1.76) | 1.81 (1.2, 2.8)** |
Mild-moderate OA | 1.0 | 1.0 | 1.0 |
Severe OA | 1.01 (0.69, 1.47) | 1.13 (0.76, 1.69) | 0.86 (0.56, 1.32) |
Age | 0.99 (0.96, 1.02) | 0.95 (0.92, 0.99)* | 0.98 (0.95, 1.02) |
Pain scale, 1–10 | 1.09 (1.0, 1.17)* | 0.98 (0.91, 1.06) | 1.08 (0.99, 1.17) |
Education | 0.93 (0.78, 1.12) | 1.07 (0.88, 1.31) | 1.06 (0.85, 1.31) |
Hard-to-access Rx med | 1.0 | 1.0 | 1.0 |
No difficulty | 0.91 (0.61, 1.36) | 1.08 (0.71, 1.66) | 1.15 (0.72, 1.84) |
Model χ2 | 13.8 (p = .05) | 18.6 (p = .01) | 14.8 (p = .04) |
Note: Results from logistic regression models, n = 551.
p = .08.
p < .05.
p < .01.